GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Novavax NVAX · USD

Health Care · US listing · 🇺🇸 United States

Compare

10.89

+1.02%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Novavax and similar listings

Same market and sector, closest in size

Name Last closeMarket valueP/ENet marginYield Change
Novavax NVAX 10.89$1.66bn3.739.2%— +1.02%
Collegium Pharmaceutical COLL 24.71$781.1m11.98.1%— +2.07%
Vir Biotechnology VIR 13.65$2.18bn—-638.9%— +11.75%
Procept Biorobotics PRCT 22.37$1.24bn—-31.0%— +8.49%
Nektar Therapeutics NKTR 37.83$769.4m—-297.1%— +1.52%
Ardent Health ARDT 17.97$2.57bn8.12.1%— +3.87%
Trevi Therapeutics TRVI 15.31$2.06bn——— +6.84%
Neogenomics NEO 17.60$2.23bn—-14.9%— +4.51%
Immunocore Holdings IMCR 31.73$1.61bn—-8.9%— +2.39%

Closes are in the currency each stock trades in. Blank figures mean we hold no company data for that listing yet.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.